This article has updated from a previous version to correct the amount raised in WaferGen's direct offering.

By Ben Butkus

WaferGen Biosystems today announced the closing of a $7.2 million registered direct offering, which has netted the company $6.7 million to bolster its dwindling cash reserves and prepare its SmartChip real-time PCR system for commercial launch.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.